Erratum: Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential (Leukemia (2006) 20 (870-876) DOI:10.1038/sj.leu.2404157);Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential

Leukemia

Volumn 20, Issue 5, 2006, Pages 870-876

  Rathinam, C ^a   Sauer, M ^a   Ghosh, A ^a   Rudolph, C ^a   Hegazy, A ^a   Schlegelberger, B ^a   Welte, K ^a   Klein, Christoph ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Dendritic cells; Hematopoietic progenitor cells; Immortalization; Notch 1

Indexed keywords

ATAXIN 1; CYTOKINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NOTCH1 RECEPTOR; RECOMBINANT INTERLEUKIN 3; STEM CELL FACTOR RECEPTOR; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENE TRANSFER; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; KARYOTYPE; MOUSE; NONHUMAN; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; RETROVIRUS; TUMOR IMMUNITY;

EID: 33646126522     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.132     Document Type: Erratum

References (25)

1. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5: 296-306.
2. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: Mapping the way. Nat Med 2004; 10: 475-480.
3. Tsai S, Bartelmez S, Sitnicka E, Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 1994; 8: 2831-2841.
4. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 2000; 6: 1278-1281.
5. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003; 9: 1428-1432.
6. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409-414.
7. Maillard I, Fang T, Pear WS. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 2005; 23: 945-974.
8. Kawamata S, Du C, Li K, Lavau C. Notch1 perturbation of hemopoiesis involves non-cell-autonomous modifications. J Immunol 2002; 168: 1738-1745.
9. Lam LT, Ronchini C, Norton J, Capobianco AJ, Bresnick EH. Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by Notch-1. J Biol Chem 2000; 275: 19676-19684.
10. Ishiko E, Matsumura I, Ezoe S, Gale K, Ishiko J, Satoh Y et al. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem 2005; 280: 4929-4939.
11. Sauer MG, Ericson ME, Weigel BJ, Herron MJ, Panoskaltsis-Mortari A, Kren BT et al. A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo-generated leukemia-reactive cytotoxic T cells. Cancer Res 2004; 64: 3914-3921.
12. Schroeder T, Just U. Notch signalling via RBP-J promotes myeloid differentiation. EMBO J 2000; 19: 2558-2568.
13. Tan-Pertel HT, Walker L, Browning D, Miyamoto A, Weinmaster G, Gasson JC. Notch signaling enhances survival and alters differentiation of 32D myeloblasts. J Immunol 2000; 165: 4428-4436.
14. Milner LA, Bigas A, Kopan R, Brashem-Stein C, Bernstein ID, Martin DIK. Inhibition of granulocytic differentiation by mNotch1. Proc Natl Acad Sci USA 1996; 93: 13014-13019.
15. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002; 99: 2369-2378.
16. Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood 2003; 102: 3980-3988.
17. Radtke F, Ferrero I, Wilson A, Lees R, Aguet M, MacDonald HR. Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J Exp Med 2000; 191: 1085-1094.
18. Ohishi K, Varnum-Finney B, Serda RE, Anasetti C, Bernstein ID. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 2001; 98: 1402-1407.
19. Weijzen S, Velders MP, Elmishad AG, Bacon PE, Panella JR, Nickoloff BJ et al. The Notch ligand jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J Immunol 2002; 169: 4273-4278.
20. Schroeder T, Lange C, Strehl J, Just U. Generation of functionally mature dendritic cells from the multipotential stem cell line FDCP-mix. Br J Haematol 2000; 111: 890-897.
21. Rathinam C, Geffers R, Yucel R, Buer J, Welte K, Moroy T et al. The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity 2005; 22: 717-728.
22. Klein C, Bueler H, Mulligan RC. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med 2000; 191: 1699-1708.
23. Pear W, Aster J, Scott M, Hasserjian R, Soffer B, Sklar J et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996; 183: 2283-2291.
24. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999; 11: 299-308.
25. Sorrentino BP. Clinical strategies for expansion of haematopoietic stem cells. Nat Rev Immunol 2004; 4: 878-888.